Acta Vet. Brno 2022, 91: 217-226

In field review of Bovalto® Respi 3 and 4 efficacy in different production systems

Matthew Yarnall1, Edmond Jolivet2, Mathieu Chevalier2, Arnaud Bolon2, Marie-Pascale Tiberghien3, Milan Huňady4, Corinne Philippe2

1Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany
2Boehringer Ingelheim, Lyon, France
3Consulting, Cortambert, France
4Bioveta, Ivanovice na Hané, Czech Republic

Received November 17, 2021
Accepted June 14, 2022

Individual author index pages

Other articles of these authors

front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Indexed in DOAJ